Need a RT-PCR rapid COVID-19 test? Visit select MinuteClinic® at CVS® locations today.

 

COL112478-Coronavirus-less-scary-red-MASKED-VIRUS

Does your upcoming travel require a negative COVID-19 result taken within a few days of departure? International flights may require a RT-PCR test, the gold standard for COVID-19 testing accuracy. Help ensure that your results are accurate, valid, and delivered in time for your next flight by getting a RT-PCR rapid COVID-19 test at a select MinuteClinic at CVS location.

Features

  • Rapid: Travel-valid, official RT-PCR results delivered on-site within hours.
  • Minimally invasive: A painless, quick nasal swab collection.
  • Convenient: Visit a MinuteClinic at CVS, give a sample, and go about your day. 
  • Accurate: Help ensure that your test result fulfills requirements and get back to worry-free travel.
MinuteClinic_at_CVS_logo_h_reg_rgb_red

Scheduling your COVID-19 test is simple. Visit CVS testing partner TrustAssure to find a MinuteClinic location and schedule your RT-PCR rapid test appointment today.

MicrosoftTeams-image (1)

Visit the TrustAssure online scheduler to book your RT-PCR rapid COVID-19 test at a MinuteClinic at CVS today.

Schedule a test

Leaving for TrustAssure: You are now leaving thermofisher.com and going to TrustAssure, owned and operated by an independent third party.  Thermo Fisher Scientific is not responsible or liable for the content or services of TrustAssure.  Thermo Fisher Scientific does not represent TrustAssure or MinuteClinic at CVS or the customer if the parties enter transaction.  Privacy and security policies of TrustAssure may differ from those practiced by thermofisher.com.  We encourage you to review the policies and terms of all websites you may choose to visit.

Frequently asked questions

Visit https://covidcontrols.co/traveller-entry for up-to-date information on testing requirements for international destinations.

Visit https://www.gohawaii.com/travel-requirements for up-to-date information on testing requirements for Hawaii travel.

Visit https://covidcontrols.co/traveller-entry for up-to-date information on testing requirements for travel.

Visit TrustAssure for pricing information.

The nasal swab is simple, quick, painless, and minimally invasive. Unlike nasopharyngeal swabs that require insertion up your nose, this nasal swab is less invasive and is rotated around the nasal wall.

The 30-minute RT-PCR rapid test is the Accula SARS-CoV-2 Test from Thermo Fisher Scientific, a leading provider of scientific equipment, assays, and reagents.

RT-PCR (Reverse Transcriptase Polymerase Chain Reaction) is a method of detecting nucleic acid (in this case RNA, the genetic material of the SARS-CoV-2 virus) in order to determine the presence of virus in a sample. It is the most sensitive and accurate method of detecting a virus and is usually performed in a lab. The rapid RT-PCR test used here uses the same process and achieves the same level of accuracy in approximately 30 minutes at the point of care.

Nucleic Acid Amplification Tests (NAAT) are molecular tests that look at DNA or RNA. There are two different types of NAAT tests available: isothermal and RT-PCR. Data shows that PCR based tests are more accurate than isothermal tests. For more information, https://www.cdc.gov/coronavirus/2019-ncov/lab/naats.html

Whereas antigen tests detect viral proteins in a sample, RT-PCR detects viral RNA which is a more direct and sensitive method of detection leading to higher accuracy of your test. Most COVID-19 travel requires a RT-PCR test because of its greater accuracy over antigen tests.

This test has not been FDA cleared or approved, but has been authorized for emergency use by FDA under an EUA for use by authorized laboratories; this test has been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens; and the emergency use of this test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.

Style Sheet for Global Design System